Maternal disease control and pregnancy outcomes with anti-CD20 therapy versus natalizumab in multiple sclerosis: a systematic review.

Altamimi A, Almutairi B A, Shaybah M E, Almahmoud L E, Mazyad A A, Afash A S, Alharbi N A O, Ghibban N W, Alharbi R J M, Almohaimeed M Y, et al.